These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32336678)

  • 21. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
    Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
    Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?
    Alany RG
    Pharm Dev Technol; 2020 Jul; 25(6):649. PubMed ID: 32423342
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need.
    Zhang T; He Y; Xu W; Ma A; Yang Y; Xu KF
    Sci China Life Sci; 2020 May; 63(5):774-776. PubMed ID: 32124179
    [No Abstract]   [Full Text] [Related]  

  • 24. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertonic saline nasal irrigation and gargling should be considered as a treatment option for COVID-19.
    Ramalingam S; Graham C; Dove J; Morrice L; Sheikh A
    J Glob Health; 2020 Jun; 10(1):010332. PubMed ID: 32395245
    [No Abstract]   [Full Text] [Related]  

  • 26. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
    Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
    Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
    [No Abstract]   [Full Text] [Related]  

  • 27. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    Ison MG; Wolfe C; Boucher HW
    JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
    [No Abstract]   [Full Text] [Related]  

  • 29. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines.
    Liu X; Wang XJ
    J Genet Genomics; 2020 Feb; 47(2):119-121. PubMed ID: 32173287
    [No Abstract]   [Full Text] [Related]  

  • 31. The future of cancer research after COVID-19 pandemic: recession?
    Kourie HR; Eid R; Haddad F; Ghosn M; Sarkis DK
    Future Oncol; 2020 Jul; 16(21):1493-1495. PubMed ID: 32469283
    [No Abstract]   [Full Text] [Related]  

  • 32. Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies.
    Zhai MZ; Lye CT; Kesselheim AS
    JAMA Intern Med; 2020 Sep; 180(9):1145-1146. PubMed ID: 32427277
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
    Shah M; Sachdeva M; Dodiuk-Gad RP
    Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251
    [No Abstract]   [Full Text] [Related]  

  • 34. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 35. Chloroquine in COVID-19: the evidence.
    Gupta N; Agrawal S; Ish P
    Monaldi Arch Chest Dis; 2020 Mar; 90(1):. PubMed ID: 32231349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment considerations for patients with pemphigus during the COVID-19 pandemic.
    Shakshouk H; Daneshpazhooh M; Murrell DF; Lehman JS
    J Am Acad Dermatol; 2020 Jun; 82(6):e235-e236. PubMed ID: 32283243
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
    Nicolau DV; Bafadhel M
    Lancet Respir Med; 2020 Sep; 8(9):846-847. PubMed ID: 32738928
    [No Abstract]   [Full Text] [Related]  

  • 38. Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19.
    Naci H; Kesselheim AS; Røttingen JA; Salanti G; Vandvik PO; Cipriani A
    BMJ; 2020 Oct; 371():m3869. PubMed ID: 33067179
    [No Abstract]   [Full Text] [Related]  

  • 39. Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
    Oldenburg CE; Doan T
    Am J Trop Med Hyg; 2020 Jun; 102(6):1154-1155. PubMed ID: 32297590
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
    Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.